...
首页> 外文期刊>BMC Health Services Research >Improving access to medicines for non-communicable diseases in rural India: a mixed methods study protocol using quasi-experimental design
【24h】

Improving access to medicines for non-communicable diseases in rural India: a mixed methods study protocol using quasi-experimental design

机译:改善印度农村地区非传染性疾病药物的获取:使用准实验设计的混合方法研究方案

获取原文
           

摘要

Background India has the distinction of financing its healthcare mainly through out-of-pocket expenses by individual families contributing to catastrophic health expenditure and impoverishment. Nearly 70?% of the expenditure is on medicines purchased at private pharmacies. Patients with chronic ailments are especially affected, as they often need lifelong medicines. Over the past years in India, there have been several efforts to improve drug availability at government primary health centres. In this study, we aim to understand health system factors that affect utilisation and access to generic medicines for people with non-communicable diseases. Methods This study aims to understand if (and how) a package of interventions targeting primary health centres and community participation platforms affect utilisation and access to generic medicines for people with non-communicable diseases in the current district context in India. This study will employ a quasi-experimental design and a qualitative theory-driven approach. PHCs will be randomly assigned to one of three arms of the intervention. In one arm, PHCs will receive inputs to optimise service delivery for non-communicable diseases, while the second arm will receive an additional package of interventions to strengthen community participation platforms for improving non-communicable disease care. The third arm will be the control. We will conduct household and facility surveys, before and after the intervention and will estimate the effect of the intervention by difference-in-difference analysis. Sample size for measuring effects was calculated based on obtaining at least 30 households for each primary health centre spread across three distance-based clusters. Primary outcomes include availability and utilisation of medicines at primary health centres and out-of-pocket expenditure for medicines by non-communicable disease households. Focus group discussions with patients and in-depth interviews with health workers will also be conducted. Qualitative and process documentation data will be used to explain how the intervention could have worked. Discussion By taking into consideration several health system building blocks and trying to understand how they interact, our study aims to generate evidence for health planners on how to optimise health services to improve access to medicines. Trial registration Protocol registered on Clinical Trials Registry of India with registration identifier number CTRI/2015/03/005640 on 17th March 2015.
机译:背景技术印度的主要区别在于,其医疗保健的资金来源是个别家庭的自费支出,这些支出导致了灾难性的医疗支出和贫困。支出的近70%是用于在私人药房购买的药品。患有慢性疾病的患者尤其容易受到影响,因为他们经常需要终身服用药物。在过去的几年中,印度为提高政府一级卫生中心的药物利用率做出了数项努力。在这项研究中,我们旨在了解影响非传染性疾病患者使用和获得仿制药的卫生系统因素。方法本研究旨在了解针对印度主要地区卫生中心和社区参与平台的一揽子干预措施是否(以及如何)影响非传染性疾病患者在印度当前地区的使用和获取仿制药。这项研究将采用准实验设计和定性理论驱动的方法。 PHC将随机分配给干预措施的三个部门之一。 PHC将在一个部门中获得投入,以优化非传染性疾病的服务提供,而第二个部门将获得额外的一揽子干预措施,以加强社区参与平台,以改善非传染性疾病的护理。第三臂将是控件。我们将在干预之前和之后进行家庭和设施调查,并将通过差异分析来评估干预的效果。评估效果的样本量是基于每个主要卫生中心至少有30户家庭分布在三个基于距离的集群中而得出的。主要成果包括在初级保健中心获得和利用药品,以及非传染性疾病家庭的自付费用。还将与患者进行焦点小组讨论,并对卫生工作者进行深入访谈。定性和过程文档数据将用于解释干预的工作方式。讨论通过考虑几个卫生系统的构成要素并试图理解它们之间的相互作用,我们的研究旨在为卫生规划人员提供有关如何优化卫生服务以改善药物获取的证据。试验注册协议已于2015年3月17日在印度临床试验注册中心注册,注册标识符为CTRI / 2015/03/005640。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号